(Q80506793)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17581794%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Artesunate inhibits angiogenesis and downregulates vascular endothelial growth factor expression in chronic myeloid leukemia K562 cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17581794%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

1 reference

chronic myeloid leukemia

1 reference

1 reference

Hui-Jun Zhou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17581794%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Wei-Qin Wang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17581794%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Guo-Dong Wu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17581794%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Jun Lee

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17581794%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Ao Li

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17581794%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

24 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17581794%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

published in

Vascular Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17581794%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17581794%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17581794%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

131-138

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17581794%20AND%20SRC:MED&resulttype=core&format=json

Vascularity, angiogenesis and angiogenic factors in leukemias and myelodysplastic syndromes

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.002

Pharmacokinetics of artemisinin and artesunate after oral administration in healthy volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.002

Antimalarial dihydroartemisinin also inhibits angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.002

Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.002

Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.002

VEGF(165) promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.002

VEGF and vascular fusion: implications for normal and pathological vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.002

Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.002

Inhibition of K562 leukemia angiogenesis and growth by expression of antisense vascular endothelial growth factor (VEGF) sequence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.002

New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.002

Placental growth factor induces FosB and c-Fos gene expression via Flt-1 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.002

The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.002

Angiogenesis and leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.002

Angiogenesis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.002

7 January 2021

Molecular angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.002

Qinghaosu (artemisinin): an antimalarial drug from China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.002

Dihydroartemisinin downregulates vascular endothelial growth factor expression and induces apoptosis in chronic myeloid leukemia K562 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.002

Efficacy and concentration-response of murine anti-VEGF monoclonal antibody in tumor-bearing mice and extrapolation to humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.002

Quantitative assessment of angiogenesis in the chick embryo and its chorioallantoic membrane by computerised analysis of angiographic images

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.002

Effect of antisense VEGF cDNA transfection on the growth of chronic myeloid leukemia K562 cells in vitro and in nude mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.002

The pivotal role of VEGF in tumor angiogenesis: molecular facts and therapeutic opportunities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.002

Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.002

Clinical relevance of VEGF receptors 1 and 2 in patients with chronic myelogenous leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.002

AIDS-associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.002

Progress in the research of artemisinin-related antimalarials: an update.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.002

Apoptosis of human umbilical vein endothelial cells induced by artesunate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.002

10.1016/J.VPH.2007.05.002

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17581794%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference